世界の自家輸血システム(ATS)市場レポート2020年

QYResearchが発行した調査報告書(QYR20ST05170)
◆英語タイトル:Global Autotransfusion Systems (ATS) Sales Market Report 2020
◆商品コード:QYR20ST05170
◆発行会社(リサーチ会社):QYResearch
◆発行日:2020年9月(※2024年版があります。お問い合わせください。)
◆ページ数:139
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル、北米、ヨーロッパ、日本、アジアなど
◆産業分野:医療機器・消耗品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥592,000見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD6,000 ⇒換算¥888,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD8,000 ⇒換算¥1,184,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

QYリサーチ社の本調査レポートでは、世界の自家輸血システム(ATS)市場について種類別(連続自家輸血システム、不連続自家輸血システム)、用途別(心臓外科、非心臓外科)、地域別(北米、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2015年~2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。
・自家輸血システム(ATS)市場の概要
・世界の主要地域別自家輸血システム(ATS)市場規模2015-2026
・主要プレイヤーの競争状況・市場シェア
・世界の自家輸血システム(ATS)市場規模2015-2026:種類別(連続自家輸血システム、不連続自家輸血システム)
・世界の自家輸血システム(ATS)市場規模2015-2026:用途別(心臓外科、非心臓外科)
・自家輸血システム(ATS)の北米市場規模2015-2020
・自家輸血システム(ATS)のヨーロッパ市場規模2015-2020
・自家輸血システム(ATS)の中国市場規模2015-2020
・自家輸血システム(ATS)の日本市場規模2015-2020
・自家輸血システム(ATS)の東南アジア市場規模2015-2020
・自家輸血システム(ATS)のインド市場規模2015-2020
・主要プレイヤーの企業情報:事業概要・売上・企業動向
・自家輸血システム(ATS)の製造コスト分析
・販売チャネル、流通業者、顧客
・自家輸血システム(ATS)の市場動向・機会・課題
・調査の結論
【レポートの概要】

A recently published report by QY Research titled Global Autotransfusion Systems (ATS) Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Autotransfusion Systems (ATS) market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
Autotransfusion System (ATS) is a sophisticated device with an exceptionally effective design that provides autologous blood during surgical procedures. Autotransfusion is a process wherein a person receives their own blood for a transfusion, instead of banked allogenic (separate-donor) blood. There are two main kinds of Autotransfusion: Blood can be autologous “pre-donated” (termed so despite “donation” not typically referring to giving to one’s self) before a surgery, or alternatively, it can be collected during and after the surgery using an intraoperative blood salvage device. The latter form of Autotransfusion is utilized in surgeries where there is expected a large volume blood loss.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Autotransfusion Systems (ATS) market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Autotransfusion Systems (ATS) industry.
Based on our recent survey, we have several different scenarios about the Autotransfusion Systems (ATS) YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Autotransfusion Systems (ATS) will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Autotransfusion Systems (ATS) market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Autotransfusion Systems (ATS) market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Autotransfusion Systems (ATS) market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Autotransfusion Systems (ATS) market. The report also includes nautical information, where it shows Autotransfusion Systems (ATS) market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Autotransfusion Systems (ATS) market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Autotransfusion Systems (ATS) market.
Geographical Analysis:
Based on region, the global Autotransfusion Systems (ATS) market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Autotransfusion Systems (ATS) market are
BD (Bard)
LivaNova
Fresenius Kabi
Haemonetics
Medtronic

Segment by Type
Continuous Autotransfusion Systems
Discontinuous Autotransfusion Systems
Segment by Application
Cardiac Surgery
Non-Cardiac Surgery
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Autotransfusion Systems (ATS) market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Autotransfusion Systems (ATS) market.
• The market share of the global Autotransfusion Systems (ATS) market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Autotransfusion Systems (ATS) market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Autotransfusion Systems (ATS) market.

【レポートの目次】

1 Autotransfusion Systems (ATS) Market Overview
1.1 Autotransfusion Systems (ATS) Product Scope
1.2 Autotransfusion Systems (ATS) Segment by Type
1.2.1 Global Autotransfusion Systems (ATS) Sales by Type (2020-2026)
1.2.2 Continuous Autotransfusion Systems
1.2.3 Discontinuous Autotransfusion Systems
1.3 Autotransfusion Systems (ATS) Segment by Application
1.3.1 Global Autotransfusion Systems (ATS) Sales Comparison by Application (2020-2026)
1.3.2 Cardiac Surgery
1.3.3 Non-Cardiac Surgery
1.4 Autotransfusion Systems (ATS) Market Estimates and Forecasts (2015-2026)
1.4.1 Global Autotransfusion Systems (ATS) Sales Growth Rate (2015-2026)
1.4.2 Global Autotransfusion Systems (ATS) Revenue and Growth Rate (2015-2026)
1.4.3 Global Autotransfusion Systems (ATS) Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Autotransfusion Systems (ATS) Industry Impact
1.5.1 How the Covid-19 is Affecting the Autotransfusion Systems (ATS) Industry
1.5.1.1 Autotransfusion Systems (ATS) Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Autotransfusion Systems (ATS) Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Autotransfusion Systems (ATS) Players to Combat Covid-19 Impact

2 Autotransfusion Systems (ATS) Estimate and Forecast by Region
2.1 Global Autotransfusion Systems (ATS) Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Autotransfusion Systems (ATS) Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Autotransfusion Systems (ATS) Sales Market Share by Region (2015-2020)
2.2.2 Global Autotransfusion Systems (ATS) Revenue Market Share by Region (2015-2020)
2.3 Global Autotransfusion Systems (ATS) Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Autotransfusion Systems (ATS) Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Autotransfusion Systems (ATS) Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Autotransfusion Systems (ATS) Estimates and Projections (2015-2026)
2.4.2 Europe Autotransfusion Systems (ATS) Estimates and Projections (2015-2026)
2.4.3 China Autotransfusion Systems (ATS) Estimates and Projections (2015-2026)
2.4.4 Japan Autotransfusion Systems (ATS) Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Autotransfusion Systems (ATS) Estimates and Projections (2015-2026)
2.4.6 India Autotransfusion Systems (ATS) Estimates and Projections (2015-2026)
3 Global Autotransfusion Systems (ATS) Competition Landscape by Players
3.1 Global Top Autotransfusion Systems (ATS) Players by Sales (2015-2020)
3.2 Global Top Autotransfusion Systems (ATS) Players by Revenue (2015-2020)
3.3 Global Autotransfusion Systems (ATS) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Autotransfusion Systems (ATS) as of 2019)
3.4 Global Autotransfusion Systems (ATS) Average Price by Company (2015-2020)
3.5 Manufacturers Autotransfusion Systems (ATS) Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Autotransfusion Systems (ATS) Players (Opinion Leaders)
4 Global Autotransfusion Systems (ATS) Market Size by Type
4.1 Global Autotransfusion Systems (ATS) Historic Market Review by Type (2015-2020)
4.1.1 Global Autotransfusion Systems (ATS) Sales Market Share by Type (2015-2020)
4.1.2 Global Autotransfusion Systems (ATS) Revenue Market Share by Type (2015-2020)
4.1.3 Global Autotransfusion Systems (ATS) Price by Type (2014-2020)
4.2 Global Autotransfusion Systems (ATS) Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Autotransfusion Systems (ATS) Sales Forecast by Type (2021-2026)
4.2.2 Global Autotransfusion Systems (ATS) Revenue Forecast by Type (2021-2026)
4.2.3 Global Autotransfusion Systems (ATS) Price Forecast by Type (2021-2026)
5 Global Autotransfusion Systems (ATS) Market Size by Application
5.1 Global Autotransfusion Systems (ATS) Historic Market Review by Application (2015-2020)
5.1.1 Global Autotransfusion Systems (ATS) Sales Market Share by Application (2015-2020)
5.1.2 Global Autotransfusion Systems (ATS) Revenue Market Share by Application (2015-2020)
5.1.3 Global Autotransfusion Systems (ATS) Price by Application (2015-2020)
5.2 Global Autotransfusion Systems (ATS) Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Autotransfusion Systems (ATS) Sales Forecast by Application (2021-2026)
5.2.2 Global Autotransfusion Systems (ATS) Revenue Forecast by Application (2021-2026)
5.2.3 Global Autotransfusion Systems (ATS) Price Forecast by Application (2021-2026)

3 North America Autotransfusion Systems (ATS) Market Facts & Figures
3.2 North America Autotransfusion Systems (ATS) Sales Market Share by Company (2015-2020)
3.3 North America Autotransfusion Systems (ATS) Sales Market Share by Type (2015-2020)
3.4 North America Autotransfusion Systems (ATS) Sales Market Share by Application (2015-2020)

4 Europe Autotransfusion Systems (ATS) Market Facts & Figures
4.2 Europe Autotransfusion Systems (ATS) Sales Market Share by Company (2015-2020)
4.3 Europe Autotransfusion Systems (ATS) Sales Market Share by Type (2015-2020)
4.4 Europe Autotransfusion Systems (ATS) Sales Market Share by Application (2015-2020)

5 China Autotransfusion Systems (ATS) Market Facts & Figures
5.2 China Autotransfusion Systems (ATS) Sales Market Share by Company (2015-2020)
5.3 China Autotransfusion Systems (ATS) Sales Market Share by Type (2015-2020)
5.4 China Autotransfusion Systems (ATS) Sales Market Share by Application (2015-2020)

6 Japan Autotransfusion Systems (ATS) Market Facts & Figures
6.2 Japan Autotransfusion Systems (ATS) Sales Market Share by Company (2015-2020)
6.3 Japan Autotransfusion Systems (ATS) Sales Market Share by Type (2015-2020)
6.4 Japan Autotransfusion Systems (ATS) Sales Market Share by Application (2015-2020)

7 Southeast Asia Autotransfusion Systems (ATS) Market Facts & Figures
7.2 Southeast Asia Autotransfusion Systems (ATS) Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Autotransfusion Systems (ATS) Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Autotransfusion Systems (ATS) Sales Market Share by Application (2015-2020)

8 India Autotransfusion Systems (ATS) Market Facts & Figures
8.2 India Autotransfusion Systems (ATS) Sales Market Share by Company (2015-2020)
8.3 India Autotransfusion Systems (ATS) Sales Market Share by Type (2015-2020)
8.4 India Autotransfusion Systems (ATS) Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in Autotransfusion Systems (ATS) Business
12.1 BD (Bard)
12.1.1 BD (Bard) Autotransfusion Systems (ATS) Corporation Information
12.1.2 BD (Bard) Autotransfusion Systems (ATS) Business Overview and Total Revenue
12.1.3 BD (Bard) Autotransfusion Systems (ATS) Sales, Revenue and Gross Margin (2015-2020)
12.1.4 BD (Bard) Autotransfusion Systems (ATS) Products Offered
12.1.5 BD (Bard) Recent Development
12.2 LivaNova
12.2.1 LivaNova Autotransfusion Systems (ATS) Corporation Information
12.2.2 LivaNova Autotransfusion Systems (ATS) Business Overview and Total Revenue
12.2.3 LivaNova Autotransfusion Systems (ATS) Sales, Revenue and Gross Margin (2015-2020)
12.2.4 LivaNova Autotransfusion Systems (ATS) Products Offered
12.2.5 LivaNova Recent Development
12.3 Fresenius Kabi
12.3.1 Fresenius Kabi Autotransfusion Systems (ATS) Corporation Information
12.3.2 Fresenius Kabi Autotransfusion Systems (ATS) Business Overview and Total Revenue
12.3.3 Fresenius Kabi Autotransfusion Systems (ATS) Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Fresenius Kabi Autotransfusion Systems (ATS) Products Offered
12.3.5 Fresenius Kabi Recent Development
12.4 Haemonetics
12.4.1 Haemonetics Autotransfusion Systems (ATS) Corporation Information
12.4.2 Haemonetics Autotransfusion Systems (ATS) Business Overview and Total Revenue
12.4.3 Haemonetics Autotransfusion Systems (ATS) Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Haemonetics Autotransfusion Systems (ATS) Products Offered
12.4.5 Haemonetics Recent Development
12.5 Medtronic
12.5.1 Medtronic Autotransfusion Systems (ATS) Corporation Information
12.5.2 Medtronic Autotransfusion Systems (ATS) Business Overview and Total Revenue
12.5.3 Medtronic Autotransfusion Systems (ATS) Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Medtronic Autotransfusion Systems (ATS) Products Offered
12.5.5 Medtronic Recent Development

13 Autotransfusion Systems (ATS) Manufacturing Cost Analysis
13.1 Autotransfusion Systems (ATS) Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Autotransfusion Systems (ATS)
13.4 Autotransfusion Systems (ATS) Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Autotransfusion Systems (ATS) Distributors List
14.3 Autotransfusion Systems (ATS) Customers

15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

...

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の自家輸血システム(ATS)市場レポート2020年(Global Autotransfusion Systems (ATS) Sales Market Report 2020)]についてメールでお問い合わせはこちらでお願いします。